Novartis

Merck, Rapt, Aslan and more cut staff
Pharma Live
Wed, 07/24/24 - 11:58 am
layoffs
Merck
RAPT Therapeutics
Aslan Pharma
Caribou Biosciences
Novartis
Spark Therapeutics
‘Not prudent’ for Novartis to join GLP-1 obesity race as late-runner, says CEO
Fierce Biotech
Thu, 07/18/24 - 11:13 pm
Novartis
Pharma CEOs
obesity
Vas Narasimhan
GLP-1 agonists
Novartis CEO sees IRA impact ‘manageable’ in short run, maintains midterm growth goal
Fierce Pharma
Thu, 07/18/24 - 11:02 pm
Novartis
Pharma CEOs
Vas Narasimhan
Inflation Reduction Act
Despite layoff announcements, Novartis beats Q2 expectations
BioSpace
Thu, 07/18/24 - 11:33 am
Novartis
layoffs
earnings
Novartis closes technical R&D site in San Diego as part of ongoing restructure
Fierce Biotech
Thu, 07/11/24 - 11:24 am
Novartis
R&D
San Diego
restructuring
Mississippi judge denies drug maker’s and PhRMA’s request for preliminary injunction in 340B case
American Hospital Association
Mon, 07/8/24 - 11:35 am
Novartis
PhRMA
340B
legal
Mississippi
Takeda circles leukemia rival to Novartis' Scemblix in up to $1.3B deal with Ascentage
Fierce Pharma
Fri, 06/14/24 - 11:40 am
Takeda
Novartis
Ascentage Pharma
olverembatinib
CML
The 6 largest biopharma layoffs of 2024 so far
BioSpace
Wed, 06/12/24 - 11:59 am
layoffs
Bristol Myers Squibb
Bayer
Takeda
Pfizer
Novartis
Perrigo
Behind Big Pharma’s layoffs — is there an end in sight?
Pharma Voice
Tue, 06/11/24 - 11:22 am
layoffs
Big Pharma
Bristol Myers Squibb
Takeda
Novartis
Bayer
Novartis, Roche unit and others face Italy antitrust probe over eye drug
Reuters
Thu, 06/6/24 - 11:34 am
Novartis
Roche
Genentech
Italy
antitrust
Biogen
Samsung Bioepis
Byooviz
Top ten biopharma R&D deals of 2024
Nature
Wed, 06/5/24 - 11:24 am
R&D
Novartis
Argo Biopharmaceutical
Roche
MOMA Therapeutics
Boehringer Ingelheim
Suzhou Ribo Life Science
Eli Lilly
Isomorphic Labs
Merus
Gilead Sciences
Novo Nordisk
Neomorph
AbbVie
Umoja Biopharma
Merck KGaA
Caris Life Sciences
Voyager Therapeutics
Novartis sues Maryland over law mandating discounts for hospitals' outside pharmacies
Reuters
Sun, 06/2/24 - 02:43 pm
Novartis
Maryland
legal
340B
drug discounts
Novartis study points to larger role for targeted leukemia drug
BioPharma Dive
Fri, 05/31/24 - 10:50 am
Novartis
Scemblix
ASCO 2024
clinical trials
CML
Novartis cues up filings for remibrutinib in chronic hives
Pharmaphorum
Fri, 05/31/24 - 10:47 am
Novartis
remibrutinib
chronic hives
clinical trials
Novartis brings augmented reality tech to ASCO to simulate leukemia patient experience
Fierce Pharma
Thu, 05/30/24 - 11:32 am
Novartis
ASCO 2024
augmented reality
patients
CML
Novartis Eyes Rare Kidney Disease Approvals on Heels of Two Phase III Wins
BioSpace
Tue, 05/28/24 - 10:47 am
Novartis
kidney disease
atrasentan
IgA nephropathy
Fabhalta
Novartis Meets Offer Conditions To Buy MorphoSys In EUR 68/shr Cash Deal
NASDAQ
Fri, 05/17/24 - 11:24 am
Novartis
MorphoSys
M&A
Big Pharma’s most improved drugs: a new generation of blockbusters
Pharma Voice
Tue, 05/14/24 - 11:34 am
Big Pharma
Eli Lilly
Mounjaro
Novo Nordisk
Wegovy
JNJ
Tecvayli
Merck
Vaxneuvance
AbbVie
Qulipta
AstraZeneca
Saphnelo
Novartis
Leqvio
Roche
Genentech
Vabysmo
Amgen
Evenity
Pfizer
Vyndaqel
Why selling to Novartis made sense for Mariana
BioPharma Dive
Sun, 05/5/24 - 11:37 pm
Novartis
Mariana
M&A
JPMHC 2024
Novartis further entrenches into radiopharma with $1B Mariana buy
Fierce Biotech
Thu, 05/2/24 - 11:41 am
Novartis
M&A
Mariana Oncology
radiopharmaceuticals

Pages